People · Operator
Named in public records as an officer, director or promoter · active 2017–2021 · Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| VBI Vaccines Inc/BC | — | Pharmaceuticals | Series A | $41.6M | $145.6M | 2018 |
| Check-Cap Ltd | — | Other Health Care | Series A | $26.0M | $190.1M | 2017 |
| Imel Biotherapeutics, Inc. | — | Other Health Care | Series B | $15.0M | $222.3M | 2021 |
Tomer Kariv at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tomer Kariv on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| David Anderson | 1 | 21 |
| Steve Gillis | 1 | 13 |
| Walter Robb | 1 | 11 |
| James Martin | 1 | 9 |
| Steven Rubin | 1 | 7 |
| Scott Requadt | 1 | 5 |
| Taro Inaba | 1 | 4 |
| Jeff Baxter | 1 | 4 |
| Mary Jo Gorman | 1 | 4 |
| David E. Anderson | 1 | 3 |
| FRANCISCO DIAZ-MITOMA | 1 | 3 |
| Egidio Nascimento | 1 | 3 |
| Gary C. Robertson | 1 | 2 |
| William C. Glasier | 1 | 2 |
| Blaine McKee | 1 | 2 |
| David C. Wolfin | 1 | 2 |
| ADAM LOGAL | 1 | 2 |
| SAM CHAWLA | 1 | 2 |
| Steven Hanley | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.